αvβ3 integrin overexpression on melanoma cells could mediate tumor angiogenesis through vascular endothelial growth factor (VEGF) and angiopoietin-Tie signaling pathways, suggesting that αvβ3 integrin is a promising therapeutic target [29, 30]. Here, VEGFA is linked to melanoma.